No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
www.geherbs.com.twNo one on the platform currently holds 4911.TWO.
No tracked institution reports a position in 4911.TWO as of their last filing.
No one on the platform has traded 4911.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4911.TWOG&E Herbal Biotechnology Co., Ltd. | $28.40 | -0.35% | $2.0B | — |
| 1295.TWOSynbio Tech Inc. | $44.85 | -0.33% | $1.6B | — |
| 1733.TWApex Biotechnology Corp. | $29.90 | -1.48% | $3.0B | — |
| 1777.TWOSYN-TECH Chem. & Pharm. Co., Ltd. | $73.40 | +0.27% | $3.3B | — |
| 3205.TWOSagittarius Life Science Corp | $46.35 | -0.11% | $3.1B | — |
| 6461.TWOIntech Biopharm Corporation | $24.60 | -3.53% | $2.7B | — |
| 6634.TWOSinew Pharma Inc. | $55.90 | -6.83% | $4.0B | — |
Source: Financial Modeling Prep · peers by sector/industry